UiPath (NYSE:PATH) Stock Price Down 7.6% Following Insider Selling
by Sarita Garza · The Markets DailyShares of UiPath, Inc. (NYSE:PATH – Get Free Report) dropped 7.6% on Tuesday after an insider sold shares in the company. The company traded as low as $15.50 and last traded at $15.9380. Approximately 49,498,254 shares traded hands during mid-day trading, an increase of 77% from the average daily volume of 27,973,926 shares. The stock had previously closed at $17.24.
Specifically, CEO Daniel Dines sold 45,000 shares of the firm’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $16.61, for a total transaction of $747,450.00. Following the sale, the chief executive officer owned 28,163,585 shares of the company’s stock, valued at $467,797,146.85. This trade represents a 0.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Daniel Dines sold 45,000 shares of the business’s stock in a transaction dated Friday, January 9th. The stock was sold at an average price of $17.17, for a total transaction of $772,650.00. Following the completion of the transaction, the chief executive officer owned 28,208,585 shares of the company’s stock, valued at $484,341,404.45. This represents a 0.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In other UiPath news, CEO Daniel Dines sold 45,000 shares of the stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $17.32, for a total transaction of $779,400.00. Following the completion of the sale, the chief executive officer directly owned 28,253,585 shares of the company’s stock, valued at approximately $489,352,092.20. This represents a 0.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on the stock. UBS Group reaffirmed a “neutral” rating on shares of UiPath in a research report on Thursday, December 4th. Zacks Research raised shares of UiPath from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Mizuho increased their price objective on UiPath from $14.00 to $15.00 and gave the company a “neutral” rating in a report on Thursday, December 4th. BMO Capital Markets raised their price objective on UiPath from $13.00 to $17.00 and gave the stock a “market perform” rating in a research report on Thursday, December 4th. Finally, Canaccord Genuity Group boosted their target price on UiPath from $15.00 to $19.00 and gave the stock a “buy” rating in a research note on Thursday, December 4th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $16.00.
View Our Latest Analysis on PATH
Trending Headlines about UiPath
Here are the key news stories impacting UiPath this week:
- Positive Sentiment: Recent results and product traction: UiPath continues to show revenue and EPS beats (Q3 2025 revenue +15.9% and an EPS beat), and management has highlighted accelerating adoption of AI agents and Maestro orchestration — positive fundamentals that support upside over time. MarketBeat: PATH company/earnings summary
- Positive Sentiment: Momentum & analyst commentary: Recent Zacks pieces argue PATH is regaining market confidence and has momentum as AI automation adoption improves, which can attract momentum-focused flows. Zacks: Momentum stock piece
- Positive Sentiment: Positioning in AI theme: MarketBeat’s AI roundup lists UiPath as a cross-cloud/agentic-AI play, reinforcing longer-term thematic interest from AI-focused investors. MarketBeat: 5 AI stocks
- Positive Sentiment: Event visibility: UiPath presented at the Needham Growth Conference (transcript available), giving investors fresh management commentary on strategy and execution. Positive conference commentary can support sentiment if details on client wins/product metrics resonate. Seeking Alpha: Needham transcript
- Neutral Sentiment: Analyst/valuation backdrop: Consensus remains a “Hold” with a ~$16 target; some boutiques have nudged targets higher while several analysts remain cautious — this mixed guidance can limit large rallies. MarketBeat: analyst consensus
- Negative Sentiment: Insider selling pressure: CEO Daniel Dines has sold multiple 45k-share blocks in early Jan. (latest disclosed sale ~45,000 shares at ~$16.61), a string of sales that may stoke short-term selling pressure and investor concern despite his large remaining stake. InsiderTrades: CEO sells
UiPath Stock Performance
The stock has a 50 day moving average of $15.67 and a 200-day moving average of $13.85. The company has a market cap of $8.52 billion, a PE ratio of 37.95, a price-to-earnings-growth ratio of 4.79 and a beta of 1.08.
UiPath (NYSE:PATH – Get Free Report) last announced its quarterly earnings data on Wednesday, December 3rd. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.02. UiPath had a return on equity of 3.73% and a net margin of 14.79%.The business had revenue of $411.11 million for the quarter, compared to analyst estimates of $392.46 million. During the same period in the prior year, the company earned $0.11 earnings per share. The company’s revenue was up 15.9% on a year-over-year basis. Equities research analysts forecast that UiPath, Inc. will post -0.17 EPS for the current year.
Hedge Funds Weigh In On UiPath
A number of institutional investors have recently bought and sold shares of the business. Noble Wealth Management PBC purchased a new stake in shares of UiPath in the 4th quarter valued at $25,000. Twin Peaks Wealth Advisors LLC acquired a new position in UiPath during the second quarter valued at $28,000. AdvisorNet Financial Inc boosted its holdings in UiPath by 320.4% in the second quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company’s stock valued at $32,000 after purchasing an additional 1,887 shares during the last quarter. GAMMA Investing LLC boosted its holdings in UiPath by 48.0% in the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock valued at $38,000 after purchasing an additional 969 shares during the last quarter. Finally, IFP Advisors Inc grew its position in UiPath by 508.0% during the 2nd quarter. IFP Advisors Inc now owns 3,283 shares of the company’s stock worth $42,000 after purchasing an additional 2,743 shares during the period. 62.50% of the stock is owned by hedge funds and other institutional investors.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.